Importantly, beside survival, chemokines in general, and CXCL12 in particular, are also powerful activators of the MAP kinase (ERK1/2) cascade, the most studied proliferative mechanism responsible of tumor growth [30, 36]. The gene discussed is MAPK3; the disease is neoplasm.